Follow Us

header ads
header ads

Clinical Communication & Collaboration Market is Estimated to Reach Close to US$ 4.2 Bn by 2030

The global clinical communication and collaboration market size is expected to reach around US$ 4.2 billion by 2030 from US$ 1.5 billion in 2021 and is expected to grow at an impressive double-digit rate of 11.6% from 2021 to 2030.

Clinical Communication and Collaboration Market Size 2021 to 2030

The study includes drivers and restraints of this market. The study provides an analysis of the global clinical communication and collaboration market for the period 2017-2030, wherein 2021 to 2030 is the forecast period and 2020 is considered as the base year.

We customize your report according to your research need. REQUEST CUSTOMIZED COPY OF REPORT (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/customization/1368

Clinical communication and collaboration is the IT system that helps the clinicians and clinical staff members to communicate and collaborate regarding the patient related activities. There are various benefits associated with the deployment of the clinical communication and collaboration systems such as enhanced care quality, improved care transitions, saving response and waiting time, and helps to improve the overall efficiency of the clinic care. The rising awareness regarding the availability of CC&C systems across the hospitals and clinics is expected to drive the demand for the CC&C, during the forecast period.

Moreover, rising penetration and development of healthcare sector across developed and developing nations is anticipated to drive the global clinical communication and collaboration market. The increased demand for the automated and technologically advanced systems in the healthcare sector to improve the quality and efficiency of healthcare units is a trending factor in the market. Therefore the trend of adopting advanced technologies in the healthcare units is expected to drive the global clinical communication and collaboration market, during the forecast period.

Further key findings in the report

  • By offering, the solution segment accounted for largest revenue share in 2019. Clinical communication and collaboration solutions allow healthcare systems to improvise clinical documentation improvements, which is a vital component for collaboration in healthcare systems. Clinical documentation improvements increase operational efficiency by allowing real-time sharing of medical documents with doctors, medical staff, and patient.

  • Growing use of smart wearables, such as smartwatches to monitor heart rate, step count, and ECG is also driving market growth.

  • Asia Pacific clinical communication and collaboration market revenue is expected to register the fastest growth rate during the forecast period, owing to growing popularity of telemedicine in countries in the region. Besides, several government initiatives to enable large scale access to telemedicine and growing digitization of the healthcare sector in the countries in the region is driving market growth.

Why should you invest in this report?

If you are aiming to enter the global clinical communication and collaboration market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for clinical communication and collaboration are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030, so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Some of the prominent players in the global clinical communication and collaboration market include:

  • Vocera Communications, Inc.
  • Jive Sotware
  • Microsoft Corporation
  • Everbridge
  • Ascom
  • TigerConnect
  • Cisco Systems Inc.
  • UDG Healthcare PLC
  • Spok Inc.
  • NEC Corporation
  • Intelligent Business Communication
  • Voalte

Market Segmentation:

By Component

  • Solution
  • Service

By End Use

  • Hospitals
  • Clinics

By Deployment

  • Hosted
  • On-Premise

Regional Analysis:

The geographical analysis of the global clinical communication and collaboration market has been done for North America, Europe, Asia-Pacific, and the Rest of the World.

The North American Market is again segmented into the US, Canada, and Mexico. Coming to the European Market, it can be segmented further into the UK, Germany, France, Italy, Spain, and the rest. Coming to the Asia-Pacific, the global clinical communication and collaboration Market is segmented into China, India, Japan, and Rest of Asia Pacific. Among others, the market is segmented into the Middle East and Africa, (GCC, North Africa, South Africa and Rest of the Middle East & Africa).

Key Questions Answered by the Report:

  • What will be the size of the global clinical communication and collaboration market in 2030?
  • What is the expected CAGR for the clinical communication and collaboration market between 2021 and 2030?
  • Which are the top players active in this global market?
  • What are the key drivers of this global market?
  • How will the market situation change in the coming years?
  • Which region held the highest market share in this global market?
  • What are the common business tactics adopted by players?
  • What is the growth outlook of the global clinical communication and collaboration market?

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Clinical Communication and Collaboration Market 

5.1. COVID-19 Landscape: Clinical Communication and Collaboration Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Clinical Communication and Collaboration Market, By Component

8.1. Clinical Communication and Collaboration Market, by Component Type, 2021-2030

8.1.1. Solution

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Service

8.1.2.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Clinical Communication and Collaboration Market, By End Use

9.1. Clinical Communication and Collaboration Market, by End Use, 2021-2030

9.1.1. Hospitals

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Clinics

9.1.2.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Clinical Communication and Collaboration Market, By Deployment 

10.1. Clinical Communication and Collaboration Market, by Deployment, 2021-2030

10.1.1. Hosted

10.1.1.1. Market Revenue and Forecast (2019-2030)

10.1.2. On-Premise

10.1.2.1. Market Revenue and Forecast (2019-2030)

Chapter 11. Global Clinical Communication and Collaboration Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Component (2019-2030)

11.1.2. Market Revenue and Forecast, by End Use (2019-2030)

11.1.3. Market Revenue and Forecast, by Deployment (2019-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Component (2019-2030)

11.1.4.2. Market Revenue and Forecast, by End Use (2019-2030)

11.1.4.3. Market Revenue and Forecast, by Deployment (2019-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Component (2019-2030)

11.1.5.2. Market Revenue and Forecast, by End Use (2019-2030)

11.1.5.3. Market Revenue and Forecast, by Deployment (2019-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Component (2019-2030)

11.2.2. Market Revenue and Forecast, by End Use (2019-2030)

11.2.3. Market Revenue and Forecast, by Deployment (2019-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Component (2019-2030)

11.2.4.2. Market Revenue and Forecast, by End Use (2019-2030)

11.2.4.3. Market Revenue and Forecast, by Deployment (2019-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Component (2019-2030)

11.2.5.2. Market Revenue and Forecast, by End Use (2019-2030)

11.2.5.3. Market Revenue and Forecast, by Deployment (2019-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Component (2019-2030)

11.2.6.2. Market Revenue and Forecast, by End Use (2019-2030)

11.2.6.3. Market Revenue and Forecast, by Deployment (2019-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Component (2019-2030)

11.2.7.2. Market Revenue and Forecast, by End Use (2019-2030)

11.2.7.3. Market Revenue and Forecast, by Deployment (2019-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Component (2019-2030)

11.3.2. Market Revenue and Forecast, by End Use (2019-2030)

11.3.3. Market Revenue and Forecast, by Deployment (2019-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Component (2019-2030)

11.3.4.2. Market Revenue and Forecast, by End Use (2019-2030)

11.3.4.3. Market Revenue and Forecast, by Deployment (2019-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Component (2019-2030)

11.3.5.2. Market Revenue and Forecast, by End Use (2019-2030)

11.3.5.3. Market Revenue and Forecast, by Deployment (2019-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Component (2019-2030)

11.3.6.2. Market Revenue and Forecast, by End Use (2019-2030)

11.3.6.3. Market Revenue and Forecast, by Deployment (2019-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Component (2019-2030)

11.3.7.2. Market Revenue and Forecast, by End Use (2019-2030)

11.3.7.3. Market Revenue and Forecast, by Deployment (2019-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Component (2019-2030)

11.4.2. Market Revenue and Forecast, by End Use (2019-2030)

11.4.3. Market Revenue and Forecast, by Deployment (2019-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Component (2019-2030)

11.4.4.2. Market Revenue and Forecast, by End Use (2019-2030)

11.4.4.3. Market Revenue and Forecast, by Deployment (2019-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Component (2019-2030)

11.4.5.2. Market Revenue and Forecast, by End Use (2019-2030)

11.4.5.3. Market Revenue and Forecast, by Deployment (2019-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Component (2019-2030)

11.4.6.2. Market Revenue and Forecast, by End Use (2019-2030)

11.4.6.3. Market Revenue and Forecast, by Deployment (2019-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Component (2019-2030)

11.4.7.2. Market Revenue and Forecast, by End Use (2019-2030)

11.4.7.3. Market Revenue and Forecast, by Deployment (2019-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Component (2019-2030)

11.5.2. Market Revenue and Forecast, by End Use (2019-2030)

11.5.3. Market Revenue and Forecast, by Deployment (2019-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Component (2019-2030)

11.5.4.2. Market Revenue and Forecast, by End Use (2019-2030)

11.5.4.3. Market Revenue and Forecast, by Deployment (2019-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Component (2019-2030)

11.5.5.2. Market Revenue and Forecast, by End Use (2019-2030)

11.5.5.3. Market Revenue and Forecast, by Deployment (2019-2030)

Chapter 12. Company Profiles

12.1. Vocera Communications, Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Jive Sotware

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Microsoft Corporation

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Everbridge

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Ascom

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. TigerConnect

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Cisco Systems Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. UDG Healthcare PLC

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Spok Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. NEC Corporation

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

12.11. Intelligent Business Communication

12.11.1. Company Overview

12.11.2. Product Offerings

12.11.3. Financial Performance

12.11.4. Recent Initiatives

12.12. Voalte

12.12.1. Company Overview

12.12.2. Product Offerings

12.12.3. Financial Performance

12.12.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1368

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com

Follow us on LinkedIn | Twitter | Facebook

Post a Comment

0 Comments